Navigation Links
Poniard Pharmaceuticals to Focus Company Resources on Late-Stage Oncology Candidate Picoplatin Through Realignment of Research Organization
Date:3/20/2009

travenous picoplatin include a Phase 3 trial in small cell lung cancer and Phase 2 trials in metastatic colorectal and castration-resistant (hormone refractory) prostate cancers. The Company also is conducting a clinical trial of oral picoplatin in solid tumors. For additional information please visit http://www.poniard.com.

This release contains forward-looking statements, including statements regarding the Company's results of clinical trials to date, business objectives and strategic goals, drug development plans, the potential safety and efficacy of its products in development and commercialization strategy. The Company's actual results may differ materially from those indicated in these forward-looking statements based on a number of factors, including risks and uncertainties associated with the Company's research and development activities; the results of clinical testing; the receipt and timing of FDA and other required regulatory approvals; the market's acceptance of the Company's proposed products; the Company's anticipated operating losses, need for future capital and ability to obtain future funding; competition from third parties; the Company's ability to preserve and protect intellectual property rights; the Company's dependence on third-party manufacturers and suppliers; the Company's lack of sales and marketing experience; the Company's ability to attract and retain key personnel; changes in technology, government regulation and general market conditions; and the risks and uncertainties described in the Company's current and periodic reports filed with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K for the year ended December 31, 2008. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. The Company undertakes no obligation to update any forward-lookin
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Poniard Pharmaceuticals to Present at Needham & Companys Cancer Therapeutics: Today & Tomorrow Conference
2. Poniard Pharmaceuticals Receives Going Concern Qualification
3. Poniard Pharmaceuticals Announces Appointment of Greg Weaver as Chief Financial Officer
4. Poniard Pharmaceuticals Provides 2009 Clinical Data Goals for Picoplatin
5. Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update
6. Poniard Pharmaceuticals Reports Second Quarter 2008 Financial Results and Corporate Update
7. Poniard Pharmaceuticals Announces Upcoming Conference Participation
8. Triax Pharmaceuticals, Providers of the No. 1 Prescribed Mid-Potency Corticosteroid Brand, Introduce a New Size of Locoid Lotion 0.1%
9. Triax Pharmaceuticals, Providers of the No. 1 Prescribed Mid-Potentcy Corticosteroid Brand, Introduce a New Size of Locoid Lotion 0.1%
10. Endo Pharmaceuticals Announces Successful Completion of Tender Offer for Indevus Pharmaceuticals
11. Valeant Pharmaceuticals Appoints President of Valeant Pharmaceuticals International
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... (PRWEB) March 28, 2015 Healthpointe’s otolaryngologists, ... nose and throat disorders, are now offering a ... common issue which is characterized by the presence of ... in 5 people, tinnitus is a prevalent symptom that ... while it is non-fatal, tinnitus can impede a person’s ...
(Date:3/28/2015)... ARDX will sponsor the 7th Annual Women’s Wellness Celebration on ... Center in Chesapeake, Virginia. Each year, ARDX celebrates Women’s ... the Hampton Roads region. The 2015 Women’s History Month ... grow stronger through sharing their stories and learning the strategies ... theme is T-talk where we will share a cup of ...
(Date:3/28/2015)... LTW Cyber is an innovation hub for technology ... of addressing the needs of the global market for ... to grow while seeking collaborative opportunities with the other ... in LTW Cyber focus on secure application security, grounded ... and analyzing open source. As the hub matures, ...
(Date:3/27/2015)... March 27, 2015 In her mid-forties and ... her from working, Monica K. arrived at JET Uniform ... department quiet, defensive and scared. The owners and staff at ... Services (EPSS) to offer jobs to challenged residents like ... and a willingness to begin with the end in mind,” ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 First Choice ... today. The new facility is located 12665 W Lake Houston ... a resident of Summerwood, I look forward to delivering the ... Dr. Sowell, Facility Medical Director of First Choice Emergency Room ... Emergency Room made a donation to Summer Creek High School ...
Breaking Medicine News(10 mins):Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2Health News:Canadian Cybersecurity Ventures Globalize as a Collective 2Health News:Canadian Cybersecurity Ventures Globalize as a Collective 3Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 2Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 3Health News:First Choice Emergency Room Opens New Facility in Houston, Texas 2
... New Component Streamlines Safe ... ... PhaSeal System for the safe handling of hazardous drugs, now offers the Secondary Set (C60) for ... ease of use, the non-vented Secondary Set offers the following features:, , , ...
... Nov.1 issue of the journal Sleep shows that ... of sleep disturbances. Findings suggest that this general improvement in ... demands and stress rather than from actual health benefits of ... sleep in the seven years after retirement were 26 percent ...
... Previous studies have shown that hepatitis C virus ... Americans than in whites. However, researchers demonstrate in this ... of the American Association for the Study of Liver ... that recurrent HCV in the transplanted liver progresses faster ...
... at increased risk of deatheven compared to patients at ... research being presented at the American Society of Nephrology,s ... "Our study indicates that body fat may be ... at Harbor-UCLA). "The results add to the increasing number ...
... found that hepatitis B does not increase the risk for pancreatic ... The results contradict a previous study in 2008 that suggested ... B is an inflammation of the liver caused by a viral ... for the Study of Liver Diseases, Annual Meeting in Boston. ...
... House speaker Nancy Pelosi is scheduled to speak about ... growing coalition of community groups and healthcare partners that are ... can cause liver cancer and damage, or if untreated, death. ... & Toland is a part, promotes hepatitis B screening, vaccination ...
Cached Medicine News:Health News:Carmel Pharma Introduces PhaSeal Secondary Set (C60) 2Health News:Study shows that sleep disturbances improve after retirement 2Health News:African Americans Fare Worse After Undergoing Liver Transplantation Due to Hepatitis C 2Health News:African Americans Fare Worse After Undergoing Liver Transplantation Due to Hepatitis C 3Health News:For dialysis patients, skinny is dangerous 2Health News:Brown & Toland Supports Fight Against Hepatitis B 2
(Date:3/27/2015)... 27, 2015  Victoria Vein & Surgery Clinic is the ... Duality laser in Victoria, Texas . The ... as advanced laser treatments for a variety of medical and ... to provide more services for their patients. Since adding laser ... Victoria residents get rid of their unwanted ...
(Date:3/27/2015)... NEW YORK , March 27, 2015 A ... Latin America – Chile ... Peru are top targets for IVD firms.  The ... figures heavily into IVD strategies for the Latin American ... industry to support globally distributed supply operations. However, the country,s ...
(Date:3/27/2015)... 27, 2015 XRpro Sciences, Inc., a ... and development services which features high throughput transporter ... announced financial results for the year ended December ... Chairman of XRpro Sciences commented, "We have completed ... development stage to commercial stage in large part ...
Breaking Medicine Technology:Victoria Vein And Surgery Clinic Uses Advanced Astanza Duality Tattoo Removal Technology 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 4XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4
... largest single market growth opportunity in global nutrition.  Abbott expects ... $1 billion (USD) by the end of 2014. China also continues ... In the first half of the year, more than 26 ... nearly 42 percent of Abbott Nutrition,s global sales were in ...
... Aug. 16, 2011 Accuray Incorporated ... announced today that the Beth Israel Deaconess Medical Center ... a leader in pioneering innovative technology to advance patient care, ... Robotic Radiosurgery System. The first center in New England to ...
Cached Medicine Technology:Abbott Expanding Manufacturing Capacity in China to Meet Demands of Fast-Growing Nutrition Market 2Beth Israel Deaconess Medical Center Treats 2,000th Patient with the CyberKnife System 2Beth Israel Deaconess Medical Center Treats 2,000th Patient with the CyberKnife System 3Beth Israel Deaconess Medical Center Treats 2,000th Patient with the CyberKnife System 4
... has created this extremely versatile and efficient ... liquid handling. With EDOS, high sample throughput ... with ease. ,The smallest volume that ... corresponding Combitip. The easy-to-follow user menus presented ...
... Dilutor-Dispenser is designed to transfer ... the clinical, biological, and chemical ... and performance as Gilsons other ... is ideal for routine laboratory ...
... synQUAD technology is a patented non-contact dispensing ... with a microsolenoid valve and stage stepper ... of liquid onto various slides, plates, or ... well, coefficient of variation (CVs) are less ...
16 channel Parallel dispenser using Positive Air Displacement Technology...
Medicine Products: